Preclinical Immunogenicity of a 6-Valent GBS Glycoconjugate Vaccine from a Repeat-Dose GLP Toxicology Study
Sign Up to like & getrecommendations! Published in 2025 at "Vaccines"
DOI: 10.3390/vaccines13090952
Abstract: Background/Objectives: Group B Streptococcus (GBS) is a significant cause of perinatal infection in neonates and infants. Complications could include neonatal sepsis and meningitis, preterm birth, stillbirth, or death. Though no GBS vaccine is currently licensed,… read more here.
Keywords: dose glp; gbs; repeat dose; vaccine ... See more keywords